Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Interleukin-17 and B cell-activating factor in Kawasaki disease and juvenile systemic lupus erythematosus — Sung Jin Park (2012) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Interleukin-17 and B cell-activating factor in Kawasaki disease and juvenile systemic lupus erythematosus
JS
Shared by
Jae Il Shin
Interleukin-17 and B cell-activating factor in Kawasaki disease and juvenile systemic lupus erythematosus
Letter
2012
en
Authors
SP
Sung Jin Park
JS
Jae Il Shin
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Letter
2013
The role of interleukin-17 in the associations between systemic lupus erythematosus and ANCA-associated vasculitis
Ji Eun Kim
,
Se Jin Park
,
Jae Il Shin
Article
2001
B-Cell Kinase Lyn Deficiency in Patients with Systemic Lupus Erythematosus
Stamatis‐Nick C. Liossis
,
Elena E. Solomou
,
Meletios A Dimopoulos
,
Panayiotis Panayiotidis
,
Myron M. Mavrikakis
,
Petros P. Sfikakis
Letter
2011
The link of HLA-B27 with interleukin-23/interleukin-17 axis in coexisting systemic lupus erythematosus and ankylosing spondylitis
Sun Ju Park
,
Ji Hong Kim
,
KS Pai
,
Jae Il Shin
Letter
2011
The role of interleukin-23/interleukin-17 axis in the development of systemic lupus erythematosus among patients with tuberculosis
Se Jin Park
,
Ji Hong Kim
,
Tae Sun Ha
,
Jae Il Shin
Letter
2012
Could Increased Vascular Endothelial Growth Factor Induced by Interleukin 17 Be the Cause of Posterior Reversible Encephalopathy Syndrome in Systemic Lupus Erythematosus?
Se Jin Park
,
Ki Soo Pai
,
Ji Hong Kim
,
Jae Il Shin
Discussion(0)
No comments yet. Be the first to comment.